Top Doctor at University of Hong Kong Suggests Aggressively Treat COVID-19 Patients Early with Antiviral Cocktail Medications: Hong Kong’s […]
Eisai Co., Ltd. announced today that it has entered into a joint research agreement with four research organizations (KAN Research […]
Could the investigational drug leronlimab prevent the deadly “cytokine storm” that threatens some severe COVID-19 patients? That is the hope […]
TrialSite News recently had the honor of interviewing Graham Kelly, a brilliant scientist, researcher, and Executive Chairman and CEO of […]
